drugset / Trial / NCT00236080

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

NCT00236080

Phase 3 Completed 136 enrolled Cephalon
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to compare the overnight efficacy and plasma concentration-time profiles of armodafinil and PROVIGIL, after multiple doses, in patients with excessive sleepiness associated with chronic Shift Work Sleep Disorder (SWSD).

Timeline

Start
2005-08
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Armodafinil Small molecule 150 mg
Subject Armodafinil Small molecule 200 mg
Subject Armodafinil Small molecule 250 mg
Subject Modafinil Small molecule 200 mg